1.Appropriate Use of Surgical Antibiotic Prophylaxis
Journal of Korean Medical Science 2019;34(17):e136-
No abstract available.
Antibiotic Prophylaxis
3.Evaluating the clinical endpoint of antibiotic prophylaxis for cirrhosis patients complicated with upper gastrointestinal bleeding: An updated systematic review and meta-analysis
Putu Itta Sandi Lesmana Dewi ; Kadek Mercu Narapati Pamungkas ; Ni Luh Putu Yunia Dewi ; Ni Nyoman Gita Kharisma Dewi ; Dwijo Anargha Sindhughosa ; I Ketut Mariadi
Acta Medica Philippina 2024;58(Early Access 2024):1-10
Background and Objective:
Antibiotic prophylaxis is used to prevent bacterial infections and rebleeding in cirrhosis patients with upper gastrointestinal bleeding (UGIB). However, the effects of various antibiotics on patients with UGIB are still being considered. This study aims to evaluate the effect of antibiotic prophylaxis on cirrhosis patients with UGIB.
Methods:
The studies were searched through databases of PubMed, ScienceDirect, Wiley Online Library, and CENTRAL from 2013 to 2023. We used Revman 5.4 to perform a meta-analysis. I2 statistics measured the heterogeneity test. The odds ratio (OR) and 95% confidence interval (CI) were used to assess the effect of antibiotic prophylaxis.
Results:
Twelve studies involving 14,825 cirrhosis patients were included in this study. Based on the meta-analysis, antibiotic prophylaxis significantly lowered the bacterial infection rate (OR: 0.29, 95%CI: 0.10 to 0.84, P = 0.02), and the incidence of serious adverse events (SAE) (OR: 0.50, 95%CI: 0.28 to 0.88, P = 0.02) in cirrhosis patients with UGIB.
Conclusions
Administration of antibiotics demonstrated a significant reduction in bacterial infection rates and SAEs. Broad-spectrum non-absorbable antibiotics can be used in cirrhosis patients with UGIB. The appropriate use of antibiotics is important to prevent resistance.
Antibiotic
;
Anti-Bacterial Agents
;
prophylaxis
;
prevention &
;
control
;
Cirrhosis
;
Fibrosis
5.Preventive administration of antibiotics to patients with benign prostatic hyperplasia before urodynamic examination.
Ning LIU ; Ming CHEN ; Shu-Qiu CHEN ; Bin XU ; Xiao-Yun MAO
National Journal of Andrology 2013;19(11):996-998
OBJECTIVETo discuss the effect and safety of preventive administration of antibiotics to patients with benign prostatic hyperplasia (BPH) before urodynamic examination.
METHODSA total of 256 BPH patients to undergo urodynamic examination were randomly divided into a control group (n = 118) and a trial group (n = 138). The former received no pre-treatment while the latter were given cefoxitin sodium iv at 1.0 g 30 minutes before complete urodynamic examination. Then we compared the incidence rates of urinary tract infection between the two groups.
RESULTSStatistically significant differences were found in the incidence rate of urinary tract infection between the control and trial groups (20.3% [24/118] vs 7.3% [10/138], P < 0.01), as well as in those with diabetes mellitus (6.7% [3/45] vs 23.5% [8/34], P < 0.05), those with residual urine > 50 ml (5.4% [3/56] vs 18.5% [10/54], P < 0.05), and those with both diabetes mellitus and residual urine (9.5% [2/21] vs 44.4% [8/18], P < 0.05). Only 3 patients (2.2%) in the trial group had mild adverse drug reactions.
CONCLUSIONFor BPH patients, particularly those with diabetes mellitus and residual urine, preventive administration of antibiotics before urodynamic examination is safe and can effectively protect the patients against urinary tract infection.
Antibiotic Prophylaxis ; Cefoxitin ; administration & dosage ; Humans ; Male ; Prostatic Hyperplasia ; diagnosis ; Urinary Tract Infections ; prevention & control ; Urodynamics
6.Endoscopic treatment of vesicoureteral reflux in pediatric patients.
Korean Journal of Pediatrics 2013;56(4):145-150
Endoscopic treatment is a minimally invasive treatment for managing patients with vesicoureteral reflux (VUR). Although several bulking agents have been used for endoscopic treatment, dextranomer/hyaluronic acid is the only bulking agent currently approved by the U.S. Food and Drug Administration for treating VUR. Endoscopic treatment of VUR has gained great popularity owing to several obvious benefits, including short operative time, short hospital stay, minimal invasiveness, high efficacy, low complication rate, and reduced cost. Initially, the success rates of endoscopic treatment have been lower than that of open antireflux surgery. However, because injection techniques have been developed, a recent study showed higher success rates of endoscopic treatment than open surgery in the treatment of patients with intermediate- and high-grade VUR. Despite the controversy surrounding its effectiveness, endoscopic treatment is considered a valuable treatment option and viable alternative to long-term antibiotic prophylaxis.
Antibiotic Prophylaxis
;
Endoscopy
;
Humans
;
Length of Stay
;
Operative Time
;
United States Food and Drug Administration
;
Vesico-Ureteral Reflux
7.Preoperative administration effect of metronidazole, ceftriaxone sodium and their combination on stenotic index of jejunal anastomotic segment of dogs.
Rehan RAFIQUE ; Muhammad Nadeem ASI ; Muhammad SAQIB ; Muhammad Hammad HUSSAIN ; Awais Ur Rehman SIAL ; Aqsa MUSHTAQ
Korean Journal of Veterinary Research 2014;54(1):27-30
The jejunum is the longest part of the small intestine and its lumen is mainly involved in the absorption of the nutrients. The present study was conducted to evaluate the effects of metronidazole, ceftriaxoine sodium and their combination on the stenotic index of the end to end jujunal anastomotic site. To accomplish this, 20 healthy stray dogs were subjected to end to end jejunal ansastmosis. Dogs in Group A (control) underwent jejunal anstomosis with no antibiotic prophylaxis, while those in Group B received surgery and metronidazole alone at 50 mg/kg, those in Group C received ceftriaxone sodium intravenously at 30 mg/kg body weight prior to surgery and dogs in Group D were given metronidazole in combination with ceftriaxone sodium at 50 mg/kg and 30 mg/kg, respectively, 2 h before surgical intervention. No significant difference (p > 0.05) in the stenotic index was observed at 14 days after jejunal anastomosis. These findings indicate that prophylactic administration of metronidazole and ceftriaxone sodium alone or in combination had no significant effect on the stenotic index of the jejunum.
Absorption
;
Animals
;
Antibiotic Prophylaxis
;
Body Weight
;
Ceftriaxone*
;
Dogs*
;
Intestine, Small
;
Jejunum
;
Metronidazole*
;
Sodium
8.Antibiotic Prophylaxis in Endoscopic Retrograde Cholangiopancreatography.
Chang Seop KIM ; Kyu Taek LEE ; Jong Kyun LEE ; Sang Goon SHIM ; Mun Suk CHOI ; In Kyung SUNG ; Poong Lyul RHEE ; Jae Jun KIM ; Kwang Cheol KOH ; Seung Woon PAIK ; Jong Chul RHEE ; Kyoo Wan CHOI
Korean Journal of Gastrointestinal Endoscopy 1999;19(6):925-929
BACKGROUND AND AIMS: Prophylactic antibiotics are used in an attempt to avoid the septic complications of endoscopic retrograde cholangiopancreatography (ERCP). But, there is individual tendency to choose prophylactic antibiotics due to a lack of definite guidelines for prophylactic antibiotics. Therefore, the effectiveness of ciprofloxacin to prevent post ERCP infectious complications was evaluated. METHODS: One hundred patients underwent 75 diagnostic ERCPs and 25, therapeutic ERCPs. They were classified randomly into a group of 51 prophylaxis (ciprofloxacin 200 mg i.v. 30 min before the procedure) and 49 controls. Pre- and post-ERCP blood cultures were prospectively performed and surveyed for infectious complications. RESULTS: Sepsis was detected in 4 patients in each group (p>0.05). Two cases were related to diagnostic ERCP and the remaining six cases, therapeutic ERCP (p<0.01). Bacteremia was found in 6 cases, but only two cases (Escherichia coli, Citrobacter freundii) were clinically significant. CONCLUSIONS: The frequency of sepsis following ERCP was not significantly reduced by antibiotic prophylaxis (7.8% vs. 8.2%).
Anti-Bacterial Agents
;
Antibiotic Prophylaxis*
;
Bacteremia
;
Cholangiopancreatography, Endoscopic Retrograde*
;
Ciprofloxacin
;
Citrobacter
;
Humans
;
Prospective Studies
;
Sepsis
9.A STUDY ON THE ANTIMICROBIAL SUSCEPTIBILITY OF ORAL MICROFLORA IN CHILDREN SUSCEPTIBLE TO INFECTIVE ENDOCARDITIS.
Sung Hwan PARK ; Sang Hun SHIN ; In Kyo CHUNG
Journal of the Korean Association of Oral and Maxillofacial Surgeons 1999;25(2):122-132
The present study has been performed to evaluate 20 cardiopathy children and 20 healthy children's oral micorbes at the point of antimicrobial susceptibilities for antimicrobial prophylaxis to prevent bacterial endocarditis. The results were as follows: 1. Both groups had similar oral microbes. 2. The antimicrobial susceptibility of S. viridans were: Penicillin< Oxacillin< Ampicillin< Cephalothin< Erythromycin< Clindamycin< Gentamicin< Ciprofloxacin< Vancomycin=Imipenem. The cardiopathy group was slightly lower antimicrobial susceptibility rates than healthy group. 3. The antimicrobial susceptibility of Neisseriaceae were: Clindamycin< Erythromycin< Vancomycin< Penicillin< Gentamicin< Cephalothin< Ciprofloxacin< Imipenem. The antibiotics of bacterial endocarditis antibiotic prophylaxis regimens for dental procedures according to the American Heart Association were generally lower antimicrobial susceptibilities, so they were considered inadequate for the first selective antibiotics and Imipemem was best suitable antimicrobials. Conclusively, when choose antimicrobials for treatment or antimicrobial prophylaxsis for bacterial endocarditis, surveillant culture must be performed to evaluated personal antimicrobial susceptibilities of intraoral microbes for proper antimicrobial choice for dental procedures.
American Heart Association
;
Anti-Bacterial Agents
;
Antibiotic Prophylaxis
;
Child*
;
Endocarditis*
;
Endocarditis, Bacterial
;
Humans
;
Imipenem
;
Neisseriaceae
10.Prospective Randomized Study for Antibiotic Prophylaxis in Spine Surgery: Choice of Drug, Dosage, and Timing.
NISHANT ; Kannan Karthick KAILASH ; P V VIJAYRAGHAVAN
Asian Spine Journal 2013;7(3):196-203
STUDY DESIGN: Prospective randomized study of antibiotic prophylaxis in elective spine surgery. PURPOSE: The aim of this study was to compare the rate of postoperative surgical site infection for a single dose of two different generations of cephalosporin with different dosage and timing of the antibiotics. OVERVIEW OF LITERATURE: Current recommendation for prophylaxis in elective spine surgery is up to 60 minutes prior to incision. No study has investigated between different generation of cephalosporin for prophylaxis in elective spine surgery with respect to choice, dosage and timing. METHODS: This study was a prospective randomized study of 90 patients, assessed for the occurrence of surgical site infection (defined by the Centers for Disease Control and Prevention criteria) and other infections for up to 6 months after surgery. Demographic, surgical and further data were collected on subsequent operations, including hardware removal. RESULTS: Mean age in our group was 47 years (range, 19-71 years). The male to female ratio was 49:41 and the average timing of administration of antibiotics was 77 minutes (range, 30-120 minutes). The average blood loss was 626 mL (range, 150-3,000 mL) with a mean duration of surgery for 3.2 hours (range, 1.5-6 hours). One case of superficial infection and one case of deep infection met the exclusion criteria. CONCLUSIONS: Our results support the use of a single preoperative dose of antibiotics in instrumented and non-instrumented elective spine surgery up to one hour prior to incision. There was no difference in terms of occurrence of surgical site infection with respect to dosage, choice and timing of antibiotics.
Anti-Bacterial Agents
;
Antibiotic Prophylaxis
;
Centers for Disease Control and Prevention (U.S.)
;
Female
;
Humans
;
Male
;
Prospective Studies
;
Spine